Clinical Trial Update: Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update describing a treat-and-extend study of intravitreal aflibercept for patients who exited protocol VGFT-OD 0910 in wet age-related m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Palmetto Retina Center, LLC | Conditions: Exudative Age-related Macular Degeneration | Phase 4 | Status: UNKNOWN